Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
European Review for Medical and Pharmacological Sciences|January 18, 2024
Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
European Review for Medical and Pharmacological Sciences|March 4, 2024
Author Correction: Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosisM Moccia, L Santoni, I Vaccari, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 25, 2012
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practiceR Lanzillo, S Bonavita, M Quarantelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A voxel-based morphometry study of disease severity correlates in relapsing-- remitting multiple sclerosisA Prinster, M Quarantelli, R Lanzillo, et al.
Acta Neurologica Scandinavica|November 24, 2011
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective studyR Lanzillo, M Quarantelli, S Bonavita, et al.
Acta Neurologica Scandinavica|September 16, 2015
SPG5 and multiple sclerosis: clinical and genetic overlap?C Criscuolo, R Carbone, M Lieto, et al.
Multiple Sclerosis and Related Disorders|January 28, 2020
Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case seriesE Signoriello, S Bonavita, L Sinisi, et al.
Multiple Sclerosis and Related Disorders|October 2, 2018
Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosisA Carotenuto, T Costabile, M Moccia, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 21, 2015
Quality of life and cognitive functions in early onset multiple sclerosisR Lanzillo, A Chiodi, A Carotenuto, et al.
European Journal of Neurology|May 19, 2011
Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patientsR Lanzillo, C Di Somma, M Quarantelli, et al.
Pageof 5